ACRS Forecast and Technical Stock Analysis
Buy candidate since 2019-12-13 PDF
Aclaris Therapeutics gained 8.67% in the last trading day ( Friday, 13th Dec 2019 ), rising from $1.73 to $1.88 During the day the stock fluctuated 12.35% from a day low at $1.70 to a day high of $1.91. The price has risen in 6 of the last 10 days and is up by 14.63% over the past 2 weeks. Volume fell in the last day by -118 598 shares and in total, 367 962 shares bought and sold for approximately $691 769.00. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.
- 30 day high of the ACRS stock price was $1.91 and low was $1.48.
- 90 day high was $2.08 and low was $1.00.
- 52 week high for Aclaris Therapeutics - $8.19 and low - $0.74.
Aclaris Therapeutics lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 34.5% during the next 3 months and, with 90% probability hold a price between $2.04 and $3.24 at the end of this period.
Aclaris Therapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $1.75 and $1.75. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday December 12, 2019, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.
Relative Strength Index (RSI)
RSImin/max Values: [ 20 - 75 ]
RSI14 is 66 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Aclaris Therapeutics finds support from accumulated volume at $1.80.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.21 between high and low, or 12.35%. For the last week the stock has had a daily average volatility of 9.16%.
Our recommended stop-loss: $1.81 (-3.69%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)
9.16 %Average volatility
Very Low Low Medium High Very High
Aclaris Therapeutics holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since last evaluation from a Sell Candidate to a Strong Buy Candidate candidate.
|ACRS $1.88 ($0.15 8.67%)|
ACRS is up $0.15 today, but where's it headed in 2020?
|Zacks Investment Research is releasing its prediction for ACRS based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ACRS analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!